Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/221900
Title: SIRT1 regulates hepatic vldlr levels
Author: Peyman, Mona
Babin-Ebell, Anna
Rodríguez-Rodríguez, Rosalía
Rigon, Matilde
Aguilar-Recarte, David
Villarroya i Terrade, Joan
Planavila Porta, Ana
Villarroya i Gombau, Francesc
Palomer Tarridas, Francesc Xavier
Barroso Fernández, Emma
Vázquez Carrera, Manuel
Keywords: Malalties del fetge
Trastorns del metabolisme dels lípids
Liver diseases
Lipid metabolism disorders
Issue Date: 1-Dec-2024
Publisher: BioMed Central
Abstract: Background Endoplasmic reticulum (ER) stress-mediated increases in the hepatic levels of the very low-density lipoprotein (VLDL) receptor (VLDLR) promote hepatic steatosis by increasing the delivery of triglyceride-rich lipoproteins to the liver. Here, we examined whether the NAD(+)-dependent deacetylase sirtuin 1 (SIRT1) regulates hepatic lipid accumulation by modulating VLDLR levels and the subsequent uptake of triglyceride-rich lipoproteins. Methods Rats fed with fructose in drinking water, Sirt1−/− mice, mice treated with the ER stressor tunicamycin with or without a SIRT1 activator, and human Huh-7 hepatoma cells transfected with siRNA or exposed to tunicamycin or different inhibitors were used. Results Hepatic SIRT1 protein levels were reduced, while those of VLDLR were upregulated in the rat model of metabolic dysfunction-associated steatotic liver disease (MASLD) induced by fructose-drinking water. Moreover, Sirt1−/− mice displayed increased hepatic VLDLR levels that were not associated with ER stress, but were accompanied by an increased expression of hypoxia-inducible factor 1α (HIF-1α)-target genes. The pharmacological inhibition or gene knockdown of SIRT1 upregulated VLDLR protein levels in the human Huh-7 hepatoma cell line, with this increase abolished by the pharmacological inhibition of HIF-1α. Finally, SIRT1 activation prevented the increase in hepatic VLDLR protein levels in mice treated with the ER stressor tunicamycin. Conclusions Overall, these findings suggest that SIRT1 attenuates fatty liver development by modulating hepatic VLDLR levels.
Note: Reproducció del document publicat a: https://doi.org/10.1186/s12964-024-01666-y
It is part of: Cell Communication and Signaling, 2024, vol. 22, p. 297
URI: https://hdl.handle.net/2445/221900
Related resource: https://doi.org/10.1186/s12964-024-01666-y
ISSN: 1478-811X
Appears in Collections:Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)

Files in This Item:
File Description SizeFormat 
862369.pdf1.92 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons